Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $178.33 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| IRONSHORE PHARMACEUTICALS INC. | $58.59 | 3 | $0 (2024) |
| ABBVIE INC. | $37.42 | 2 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $26.61 | 1 | $0 (2024) |
| Novo Nordisk Inc | $19.39 | 1 | $0 (2024) |
| Lilly USA, LLC | $18.86 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $17.46 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $145.01 | 7 | IRONSHORE PHARMACEUTICALS INC. ($58.59) |
| 2023 | $15.86 | 1 | ABBVIE INC. ($15.86) |
| 2022 | $17.46 | 1 | Gilead Sciences, Inc. ($17.46) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $19.51 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $14.26 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 07/22/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $24.82 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 06/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Diabetes | ||||||
| 02/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Diabetes | ||||||
| 12/07/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: NEUROSCIENCE | ||||||
| 05/12/2022 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: HCV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 11 | 12 | $907.00 | $116.52 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2021 | 11 | 12 | $907.00 | $116.52 | 12.8% |
About Lynne Piascik, FNP-C
Lynne Piascik, FNP-C is a Family Health healthcare provider based in Cleveland, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2018. The National Provider Identifier (NPI) number assigned to this provider is 1073088571.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lynne Piascik, FNP-C has received a total of $178.33 in payments from pharmaceutical and medical device companies, with $145.01 received in 2024. These payments were reported across 9 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($178.33).
As a Medicare-enrolled provider, Piascik has provided services to 11 Medicare beneficiaries, totaling 12 services with total Medicare billing of $116.52. Data is available for 1 year (2021–2021), covering 1 distinct procedure/service records.
Practice Information
- Specialty Family Health
- Location Cleveland, TX
- Active Since 10/11/2018
- Last Updated 10/11/2018
- Taxonomy Code 364SF0001X
- Entity Type Individual
- NPI Number 1073088571
Products in Payments
- JORNAY PM (Drug) $58.59
- Kerendia (Drug) $26.61
- VRAYLAR (Drug) $21.56
- Ozempic (Drug) $19.39
- MOUNJARO (Drug) $18.86
- Epclusa (Drug) $17.46
- UBRELVY (Drug) $15.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.